JumpCloud Launches New Community for IT Admins
New Community Connects IT Professionals on Career and Technical Topics LOUISVILLE, Colo., April 12, 2022…
Month: April 2022
Healthy Extracts Expects Q1 2022 Net Revenue up 187% to Record $489,000, Driving First Profitable Quarter
LAS VEGAS, April 12, 2022 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading…
Progenity to Become Biora Therapeutics as it Completes Transformation
Upcoming Change Reflects the Company’s Focus on Oral Delivery of Biotherapeutics SAN DIEGO, April 12,…
Rakovina Therapeutics Presents Preclinical Data Supporting Potential Broad Anticancer Activity of kt-4000 Series at the American Association of Cancer Research (AACR) Annual General Meeting
VANCOUVER, British Columbia, April 12, 2022 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (“the…
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)
MALVERN, Pa., April 12, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company…
IO Biotech Announces Initiation of Phase 2 Trial of IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Multi-Arm Basket Trial
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical…
CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”
VANCOUVER, Washington, April 12, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
Panbela Announces Poster Presentation at American Association for Cancer Research:
The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian…
Halo Elevate Officially Hits Shelves at Pet Supplies Plus
Halo’s Ground-Breaking Brand of Super Premium, Natural Pet Food will be Available at 600+ Pet…
Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 12, 2022 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations
PASADENA, CA, April 12, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a…
Celsion Corporation to Highlight its PLACCINE Platform Technology During Oral Presentation at the World Vaccine Congress
LAWRENCEVILLE, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN), a clinical-stage company focused on…
Enzo Biochem Reports Results of its Annual Meeting of Shareholders
FOR IMMEDIATE RELEASE All Four Proposals Approved NEW YORK, NY, April 12, 2022 (GLOBE NEWSWIRE)…
Aeterna Zentaris to Participate at the Virtual Investor 2022 CEO Spotlight
– Live moderated video webcast fireside chat with Dr. Klaus Paulini, CEO and Giuliano La…
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting
NEWTON, Mass. and GENEVA, April 12, 2022 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER)…
Cocrystal Pharma Reports Favorable Preliminary Data from Phase 1 Initial Cohorts with CC-42344, a Novel, Broad-Spectrum Influenza A antiviral
CC-42344 administered orally as a single 100 mg or 200 mg dose in healthy adults…
Caladrius Biosciences Treats First Patient in the Phase 1b Trial of CLBS201 for the Treatment of Diabetic Kidney Disease
BASKING RIDGE, N.J., April 12, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
ProKidney confirms Phase 3 program for autologous kidney cell therapy REACT®
Two Phase 3 controlled trials with substantially similar design to enroll 1,200 subjects with diabetic…
Chinook Therapeutics Announces Initiation of Phase 1 Healthy Volunteer Trial of CHK-336, a First-in-Class LDHA Inhibitor to Treat Hyperoxalurias
SEATTLE, April 12, 2022 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company…
Nautilus Biotechnology Appoints Gwen Weld as Chief People Officer and Sheri Wilcox, Ph.D., as Vice President of Affinity Reagent Development
Former Microsoft and SomaLogic executives join senior leadership team of company developing platform for comprehensively…